Hassan Mohwad Ibrahim, MD | |
1501 Kings Hwy, Department Of Pediatrics, Section Of Neonatology, Shreveport, LA 71103-4228 | |
(318) 675-7255 | |
(318) 675-4660 |
Full Name | Hassan Mohwad Ibrahim |
---|---|
Gender | Male |
Speciality | Pediatrics - Neonatal-perinatal Medicine |
Location | 1501 Kings Hwy, Shreveport, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093735961 | NPI | - | NPPES |
1688923 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 11168R (Louisiana) | Primary |
Entity Name | Louisiana State University Health Sciences Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417992249 PECOS PAC ID: 6103730908 Enrollment ID: O20031208000275 |
News Archive
Several new immunotherapeutic antibodies that inhibit checkpoint receptors on T cells to restimulate the immune system to target tumors have been approved to treat advanced stage lung cancer and melanoma; however, only 20 percent of lung cancer patients show a response to these agents.
A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases.
Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.
Pfizer and Bioren today announced the completion of a transaction in which Pfizer purchased all outstanding stock of Bioren for an undisclosed amount.
› Verified 5 days ago
Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Several new immunotherapeutic antibodies that inhibit checkpoint receptors on T cells to restimulate the immune system to target tumors have been approved to treat advanced stage lung cancer and melanoma; however, only 20 percent of lung cancer patients show a response to these agents.
A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases.
Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.
Pfizer and Bioren today announced the completion of a transaction in which Pfizer purchased all outstanding stock of Bioren for an undisclosed amount.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Hassan Mohwad Ibrahim, MD 1501 Kings Hwy, Department Of Pediatrics, Section Of Neonatology, Shreveport, LA 71103-4228 Ph: (318) 675-7255 | Hassan Mohwad Ibrahim, MD 1501 Kings Hwy, Department Of Pediatrics, Section Of Neonatology, Shreveport, LA 71103-4228 Ph: (318) 675-7255 |
News Archive
Several new immunotherapeutic antibodies that inhibit checkpoint receptors on T cells to restimulate the immune system to target tumors have been approved to treat advanced stage lung cancer and melanoma; however, only 20 percent of lung cancer patients show a response to these agents.
A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases.
Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.
Pfizer and Bioren today announced the completion of a transaction in which Pfizer purchased all outstanding stock of Bioren for an undisclosed amount.
› Verified 5 days ago
Shaheena Anene, Pediatrics Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Uday Kumar Chalwadi, Pediatrics Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Lea Bonifacio Penales, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2520 Bert Kouns Loop, Suite 215, Shreveport, LA 71118 Phone: 318-212-5970 Fax: 318-212-5975 | |
Marco Quispe Leveau, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 | |
Amanda Bradshaw Raney, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7045 Youree Dr, Shreveport, LA 71105 Phone: 318-798-3763 Fax: 318-797-0645 | |
Martha M Whyte, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Mary Pl, Shreveport, LA 71101 Phone: 318-227-4658 Fax: 318-424-6606 | |
Dr. Stephanie Boyd Henson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1801 Fairfield Ave, Suite 201, Shreveport, LA 71101 Phone: 318-848-2810 Fax: 318-848-2815 |